FragmentBased Drug Discovery Market to be Valued at US 88010 Mn by 2031 The Biopharmaceutical Companies Segment Accounts for the Largest Revenue Share Growth Plus Reports

Newark, New Castle, USA, April 05, 2023 (GLOBE NEWSWIRE) — According to the latest Growth Plus Reports study, the global fragment-based drug discovery market is projected to reach US$ 880.10 million by 2031, with a revenue CAGR of 8.60%. The study examines major growth strategies, market dynamics and prospects, rivalry, changing market environment, market size, data and forecasts, and significant investment regions. Key Takeaways: · The increasing prevalence of chronic conditions will drive market revenue growth. · Increasing demand for novel drugs will drive demand for fragment-based drug discovery. · North America dominates the global fragment-based drug discovery market. Request…